Financials data is unavailable for this security.
Cash flow in GBPView more
In 2023, cash reserves at SkinBioTherapeutics PLC fell by 493.09k. Cash Flow from Financing totalled 2.32m or 1,754.75% of revenues. In addition the company used 2.65m for operations while cash used for investing totalled 165.28k.
Cash flow per share | -0.0161 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0192 |
---|---|
Tangible book value per share | 0.0152 |
More ▼
Balance sheet in GBPView more
Current ratio | 6.57 |
---|---|
Quick ratio | 6.48 |
Total debt/total equity | 0.0266 |
---|---|
Total debt/total capital | 0.0259 |
More ▼